Unihealth Hospitals Limited (NSE:UNIHEALTH)
India · Delayed Price · Currency is INR 750.00
+13.00 (1.76%)
Jul 31, 2026, 3:28 PM IST
Unihealth Hospitals Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Total Valuation
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 11,775 | 5,581 | 2,156 | 2,079 | - | - | |
Market Cap Growth | 359.36% | 158.86% | 3.70% | - | - | - |
Enterprise Value | 12,601 | 6,212 | 2,013 | 1,852 | - | - |
Last Close Price | 750.00 | 362.40 | 140.00 | 135.00 | - | - |
Price Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 45.40 | 21.61 | 15.26 | 20.17 | - | - |
PS Ratio | 8.92 | 4.23 | 2.18 | 4.26 | - | - |
PB Ratio | 5.95 | 2.82 | 1.52 | 2.44 | - | - |
P/TBV Ratio | 9.16 | 4.34 | 2.34 | 2.67 | - | - |
P/FCF Ratio | - | - | - | 90.58 | - | - |
P/OCF Ratio | 206.85 | 98.04 | 65.07 | 44.47 | - | - |
EV Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
EV/Sales Ratio | 9.55 | 4.71 | 2.03 | 3.80 | - | - |
EV/EBITDA Ratio | 23.31 | 12.45 | 5.73 | 10.49 | - | - |
EV/EBIT Ratio | 28.71 | 14.24 | 6.53 | 12.02 | - | - |
EV/FCF Ratio | - | - | - | 80.69 | - | - |
Financial Efficiency
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Debt / Equity Ratio | 0.17 | 0.17 | 0.16 | 0.18 | 1.44 | 2.61 |
Debt / EBITDA Ratio | 0.61 | 0.61 | 0.60 | 0.86 | 2.88 | 3.31 |
Debt / FCF Ratio | - | - | - | 6.60 | - | 4.77 |
Net Debt / Equity Ratio | 0.11 | 0.11 | 0.05 | -0.16 | 1.37 | 2.45 |
Net Debt / EBITDA Ratio | 0.45 | 0.45 | 0.19 | -0.76 | 2.74 | 3.11 |
Net Debt / FCF Ratio | -0.87 | -0.87 | -0.51 | -5.82 | -37.70 | 4.48 |
Asset Turnover | 0.60 | 0.60 | 0.67 | 0.52 | 0.61 | 0.60 |
Inventory Turnover | 8.65 | 8.65 | 11.75 | 8.02 | 7.77 | 9.23 |
Quick Ratio | 4.58 | 4.58 | 3.39 | 5.44 | 2.05 | 1.58 |
Current Ratio | 5.33 | 5.33 | 3.78 | 5.87 | 2.32 | 1.85 |
Return on Equity (ROE) | 26.92% | 26.92% | 23.88% | 18.32% | 36.61% | 29.55% |
Return on Assets (ROA) | 12.40% | 12.40% | 13.04% | 10.22% | 9.71% | 9.43% |
Return on Invested Capital (ROIC) | 19.44% | 23.23% | 24.98% | 17.17% | 15.98% | 13.82% |
Return on Capital Employed (ROCE) | 19.40% | 19.40% | 19.70% | 15.60% | 17.40% | 18.00% |
Yields
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Earnings Yield | 2.19% | 4.63% | 6.55% | 4.96% | - | - |
FCF Yield | -2.17% | -4.58% | -5.98% | 1.10% | - | - |
Buyback Yield / Dilution | -1.54% | -1.54% | -14.54% | -21.47% | -0.00% | - |